Literature DB >> 10022451

Oncostatin M in the normal human testis and several testicular disorders.

M P De Miguel1, J Regadera, F Martinez-Garcia, M Nistal, R Paniagua.   

Abstract

The immunohistochemical reaction to oncostatin M (OSM) was studied in normal human testes at different ages (fetuses, newborns, children, pubertal boys, adults, and elderly men), as well as in several testicular disorders including carcinoma-in-situ cells (CIS), germ cell tumors, benign functioning Leydig cell tumor, androgen insensitivity syndrome, Klinefelter's syndrome, and cryptorchidism. Positive OSM immunostained Sertoli cells were only observed in fetuses. In normal testes, intense OSM immunoreaction was found in the Leydig cells of fetuses, newborns, and adults. Leydig cell immunoreaction was weak in elderly men and absent in children and pubertal boys. In some testicular disorders (Leydig cell tumor, cryptorchidism, and CIS), Leydig cell immunoreaction was as intense as in normal adult testes. This immunoreaction was heterogeneous in androgen insensitivity syndrome and was absent in Klinefelter's syndrome and intratubular seminoma. No recognizable Leydig cells were observed in the other testicular tumors. The findings of our study suggest that, in humans, the down-regulation of OSM immunoexpression in Sertoli cells occurs early, and that OSM immunoreaction in the Leydig cells is associated with functionally active and differentiated Leydig cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10022451     DOI: 10.1210/jcem.84.2.5480

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  3 in total

Review 1.  Leydig cell tumor in a patient with 49,XXXXY karyotype: a review of literature.

Authors:  Salwan Maqdasy; Laura Bogenmann; Marie Batisse-Lignier; Béatrice Roche; Fréderic Franck; Françoise Desbiez; Igor Tauveron
Journal:  Reprod Biol Endocrinol       Date:  2015-07-10       Impact factor: 5.211

2.  Oncostatin M inhibits differentiation of rat stem Leydig cells in vivo and in vitro.

Authors:  Yiyan Wang; Lubin Xie; Erpo Tian; Xiaoheng Li; Zina Wen; Linchao Li; Lanlan Chen; Ying Zhong; Ren-Shan Ge
Journal:  J Cell Mol Med       Date:  2018-10-15       Impact factor: 5.310

3.  Oncostatin-M inhibits luteinizing hormone stimulated Leydig cell progenitor formation in vitro.

Authors:  Katja J Teerds; Federica M F van Dissel-Emiliani; Maria P De Miguel; Mieke de Boer-Brouwer; Lina M Körting; Eddy Rijntjes
Journal:  Reprod Biol Endocrinol       Date:  2007-11-08       Impact factor: 5.211

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.